|
SUMO3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11879999999498E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.86299999999284E-06 |
| Normal-vs-Stage2 |
4.997900E-03 |
| Normal-vs-Stage3 |
4.138200E-03 |
| Normal-vs-Stage4 |
1.020410E-03 |
| Stage1-vs-Stage2 |
8.135200E-01 |
| Stage1-vs-Stage3 |
8.212000E-01 |
| Stage1-vs-Stage4 |
1.825430E-01 |
| Stage2-vs-Stage3 |
9.817600E-01 |
| Stage2-vs-Stage4 |
2.338800E-01 |
| Stage3-vs-Stage4 |
2.707600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81637999999706E-05 |
| Normal-vs-AfricanAmerican |
1.218960E-03 |
| Normal-vs-Asian |
2.125800E-02 |
| Caucasian-vs-AfricanAmerican |
1.946450E-01 |
| Caucasian-vs-Asian |
4.983800E-01 |
| AfricanAmerican-vs-Asian |
2.154400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.33090000000469E-05 |
| Normal-vs-Female |
1.233830E-04 |
| Male-vs-Female |
4.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.72879999996256E-06 |
| Normal-vs-Extreme_Weight |
1.029950E-04 |
| Normal-vs-Obese |
1.174420E-02 |
| Normal-vs-Extreme_Obese |
5.956200E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.361200E-01 |
| Normal_Weight-vs-Obese |
1.662270E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.668200E-01 |
| Extreme_Weight-vs-Obese |
1.358760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.013200E-01 |
| Obese-vs-Extreme_Obese |
2.709700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.80120000000362E-05 |
| Normal-vs-Age(41-60Yrs) |
9.958700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.19109999999301E-05 |
| Normal-vs-Age(81-100Yrs) |
3.263900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.042000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.510100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.168400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.402800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.034200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.674400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.230900E-04 |
| Normal-VS-Type2 PRCC |
1.00899999999626E-06 |
| Normal-VS-KIRP CIMP |
1.14630005487726E-09 |
| Normal-VS-Unclassified PRCC |
1.721110E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.659000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.0888000003897E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
2.933000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.435910E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.522200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.037240E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.7135999999054E-07 |
| Normal-vs-N1 |
9.000300E-03 |
| Normal-vs-N2 |
3.336400E-03 |
| N0-vs-N1 |
3.325000E-01 |
| N0-vs-N2 |
2.009800E-01 |
| N1-vs-N2 |
1.865850E-01 |
|
|
